Limited activity of fedratinib in myelofibrosis patients relapsed/refractory to ruxolitinib 20 mg twice daily or higher: A real-world experience.
作者信息
Gangat Naseema, McCullough Kristen, Al-Kali Aref, Begna Kebede H, Patnaik Mrinal M, Litzow Mark R, Hogan William, Shah Mithun, Alkhateeb Hassan, Mangaonkar Abhishek, Foran James M, Palmer Jeanne M, Pardanani Animesh, Tefferi Ayalew
机构信息
Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
Division of Hematology, Mayo Clinic, Jacksonville, Florida, USA.
出版信息
Br J Haematol. 2022 Aug;198(4):e54-e58. doi: 10.1111/bjh.18284. Epub 2022 May 25.
PMID:35614565
Abstract
摘要
Zotero 插件